Cargando…

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease

Despite the well-established benefits of statin treatments in lowering low-density lipoprotein cholesterol (LDL-C), a significant residual risk for atherosclerotic cardiovascular disease (ASCVD) remains. Triglycerides (TGs) have long been recognized as potential residual risk factors in this context...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, Ji Hye, Jo, Sang-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519781/ https://www.ncbi.nlm.nih.gov/pubmed/37750369 http://dx.doi.org/10.3346/jkms.2023.38.e295

Ejemplares similares

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

The Role of Triglyceride-rich Lipoproteins and Their Remnants in Atherosclerotic Cardiovascular Disease
por: Gabani, Mohanad, et al.
Publicado: (2023)

Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations
por: Lütjohann, Dieter, et al.
Publicado: (2023)

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
por: Dallinga-Thie, Geesje M., et al.
Publicado: (2016)

Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review
por: Sascău, Radu, et al.
Publicado: (2021)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
por: Chapman, M. John, et al.
Publicado: (2011)

Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study
por: Björnson, Elias, et al.
Publicado: (2023)

Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
por: Sun, Cathy J, et al.
Publicado: (2019)

Correlation of Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Stroke Patients
por: Luo, Ruiqing, et al.
Publicado: (2022)

Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

PCSK9 and triglyceride-rich lipoprotein metabolism
por: Druce, Irena, et al.
Publicado: (2015)

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
por: Ginsberg, Henry N, et al.
Publicado: (2021)

Positive Association between Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Hypertensive Patients
por: Zhou, Wei, et al.
Publicado: (2021)

Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
por: Chu, Shou-Yu, et al.
Publicado: (2019)

Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
por: Gugliucci, Alejandro
Publicado: (2023)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population
por: Cheang, Iokfai, et al.
Publicado: (2022)

Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients
por: Kim, Ji Eun, et al.
Publicado: (2019)

Remnant cholesterol is associated with cardiovascular mortality
por: Zhang, Kerui, et al.
Publicado: (2022)

Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
por: Irawati, Deasy, et al.
Publicado: (2016)

Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy
por: Reiner, Željko
Publicado: (2018)

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease
por: Cheng, Yiping, et al.
Publicado: (2023)

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
por: Kosmas, Constantine E., et al.
Publicado: (2023)

Postprandial Hyperlipidemia and Remnant Lipoproteins
por: Masuda, Daisaku, et al.
Publicado: (2017)

A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis
por: Homma, Koichiro, et al.
Publicado: (2017)

Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids
por: Hermans, Michel P, et al.
Publicado: (2014)

High Levels of Remnant Lipoprotein Cholesterol Is a Risk Factor for Large Artery Atherosclerotic Stroke
por: Kim, Jeong-Yeon, et al.
Publicado: (2011)

Age dependent association between remnant cholesterol and cardiovascular disease
por: Wang, Anxin, et al.
Publicado: (2021)

Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes
por: Jørgensen, Peter Godsk, et al.
Publicado: (2016)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data
por: Che, Bizhong, et al.
Publicado: (2023)

Triglyceride-rich lipoproteins prevent septic death in rats
Publicado: (1995)

Triglyceride to High-Density Lipoprotein Cholesterol Ratio Predicts Cardiovascular Outcomes in Prevalent Dialysis Patients
por: Chen, Hung-Yuan, et al.
Publicado: (2015)

Genomic Determinants of Triglyceride and Cholesterol Distribution into Lipoprotein Fractions in the Rat
por: Hodúlová, Miloslava, et al.
Publicado: (2014)

Correlation between Cholesterol, Triglycerides, Calculated, and Measured Lipoproteins: Whether Calculated Small Density Lipoprotein Fraction Predicts Cardiovascular Risks
por: Khan, Sikandar Hayat, et al.
Publicado: (2017)

The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease
por: Sonmez, Alper, et al.
Publicado: (2015)

Genetic Variation in SULF2 Is Associated with Postprandial Clearance of Triglyceride-Rich Remnant Particles and Triglyceride Levels in Healthy Subjects
por: Matikainen, Niina, et al.
Publicado: (2013)

Angiopoietin-Like Protein 4 May Be an Interplay Between Serum Uric Acid and Triglyceride-Rich Lipoprotein Cholesterol
por: Peng, Yani, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_glavh739k03i0g3lmag154u7be